Pharmaceuticals, Biotechnology and Life Sciences
WALTHAM, Mass., April 14, 2025 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming…
MONTREAL, April 11, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company,…
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba,, April 11, 2025 (GLOBE…
Châtillon, France, April 11, 2025 DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document…
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringeSelf-injection provides gMG and CIDP…
SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2025,…
HOLLISTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of…
Latha Vairavan Latha Vairavan, currently vice president and controller, will assume the role of CFO and join the executive team.…
Monrovia, CA, April 10, 2025 (GLOBE NEWSWIRE) — Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes…
SEATTLE, April 10, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to…